Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Eli Lilly & Co. (NY: LLY)
51.79 USD  -0.56 (-1.07%)
Streaming Delayed Price  /  Updated: 11:16 AM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Eli Lilly & Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
UPDATE 1-AstraZeneca, Bristol diabetes drug disappoints in key test
Today 2:55 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might... Read More
category companyNews
from Reuters: Company News
UPDATE 3-FDA probes deaths of two patients on Lilly schizophrenia drug
June 18, 2013
June 18 (Reuters) - The U.S. Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co.'s long-acting treatment for schizophrenia,... Read More
category companyNews
from Reuters: Company News
Daily Dividend Report: SRE, LLY, AMAT, RL, PETM
June 18, 2013
This afternoon, Sempra Energy (SRE) declared its quarterly dividend of 63 cents per share, maintaining the amount paid to shareholders the last quarter. Based on the current stock price, investors can... Read More
category Dividends
from Dividend Channel
Medtronic Saga: Corrupt Science, Belated Warning
June 18, 2013
category AZN , ABBV , MDT , and 4 more.
from YCharts
Eli Lilly (LLY) Breaks Through Support at $52.02
June 18, 2013
from Comtex SmarTrend® News Briefs
Eli Lilly & Co. (LLY) Declares $0.49 Quarterly Dividend; 3.8% Yield
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8426855 for the full story. Read More
from StreetInsider.com News Articles
Lilly Declares Third-Quarter 2013 Dividend
June 18, 2013
from PR Newswire
CORRECTED-Eli Lilly studying deaths of two patients on long-acting Zyprexa
June 18, 2013
June 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for... Read More
category companyNews
from Reuters: Company News
FDA Investigating Two Deaths Following Injection of Lilly's (LLY) Antipsychotic Zyprexa Relprevv
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8426765 for the full story. Read More
from StreetInsider.com News Articles
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
June 18, 2013
category Pharmaceuticals
from Trefis
Key to Success, How to Profit: HAL, CLF, LLY and LOW
June 17, 2013
from Marketwired News Releases
Pharma Stocks: Court Ruling's Real Meaning
June 17, 2013
category AZN , SNY , MRK , and 4 more.
from YCharts
New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia
June 17, 2013
Study results presented at ENDO 2013 Annual Meeting Read More
from PR Newswire
Lilly Diabetes, Kris Freeman Kick off Summer with 9th Annual Diabetes Summer Camp Tour
June 17, 2013
New video reveals diabetes struggles, chase for Olympic gold and the spirit of a champion Read More
from PR Newswire
Lilly Scraps An Alzheimer's Drug; What Does It Mean For Merck?
June 14, 2013
Once again, Eli Lilly has suffered a setback trying to find a useful drug to combat Alzheimer’s. Last year, a pair of late-stage trials for an injectable drug called solanezumab failed to meet primary... Read More
category NYSE:MRK , NYSE:LLY
from Forbes Real Time
StreetInsider.com Pre-Open Movers 6/14: (RH) (GRPN) (ELN) Higher; (CEMP) (HIMX) (RBCN) Lower (more...)
June 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8417561 for the full story. Read More
from StreetInsider.com News Articles
StreetInsider.com After-Hours Movers 6/13: (RH) (SWHC) (OCN) Higher; (CPST) (GNRC) (LLY) Lower (more...)
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8416298 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-Lilly halts Alzheimer's drug trial due to liver problems
June 13, 2013
June 13 (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver toxicity, the latest setback in the quest to... Read More
category companyNews
from Reuters: Company News
Lilly halts Alzheimer's drug trial because of liver problems
June 13, 2013
June 13 (Reuters) - Eli Lilly and Co said on Thursday it was halting a midstage clinical trial of an experimental Alzheimer's disease treatment due to potential liver toxicity problems. Read More
category companyNews
from Reuters: Company News
Lilly and Co. (LLY) Ceases BACE Phase II Voluntarily; Sees Immaterial Charge
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8415785 for the full story. Read More
from StreetInsider.com News Articles
Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimer's Disease
June 13, 2013
Decision does not impact other Lilly Alzheimer's compounds in development Read More
from PR Newswire
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
June 13, 2013
from PR Newswire
The $65M woman
June 13, 2013
Pepper Hamilton partner Nina Gussack controls about $65 million in business, roughly 20 percent of the firm’s revenues, according to a Q&A with The Careerist, a blog examining at how lawyers shape... Read More
category Philadelphia , Legal Services , Eli Lilly& Co/ , and 8 more.
from Business Journals
Lilly says arthritis pill effective in mid-stage study
June 13, 2013
June 13 (Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment. Read More
category companyNews
from Reuters: Company News
Lilly, Incyte Announce Baricitinib Efficacy and Safety Data from Phase 2b JADA Study in Patients with Rheumatoid Arthritis
June 13, 2013
Eli Lilly and Company (NYSE: LLY ) and Incyte Corporation (NASDAQ: INCY ) today announced 52-week efficacy and safety data from the open-label, long-term extension of the Phase 2b JADA study of... Read More
category Contracts , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis
June 13, 2013
- Results from 52-week study presented at EULAR 2013 - Read More
from PR Newswire
Pipeline vs. Expiring Patents: Eli Lilly’s Future
June 12, 2013
category JNJ , C , MRK , and 3 more.
from YCharts
NeuroTronik bags $1.7M to treat heart condition
June 12, 2013
Medical technology startup NeuroTronik has nabbed nearly $1.7 million in equity financing from two undisclosed investors, according to a securities filing... Read More
category Health Care , NeuroTronik , Eli Lilly and Company , and 1 more.
from Business Journals
Research Study Results Bring Hope for Combating Debilitating Diseases - Research Report on Johnson & Johnson, AbbVie, Lilly, Novartis and GlaxoSmithKline
June 12, 2013
from PR Newswire
Lilly to Highlight Late-Stage Pipeline Molecules at the 73rd American Diabetes Association Scientific Sessions®
June 11, 2013
Company to showcase data for investigational GLP-1 receptor agonist and investigational novel basal insulin analog Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here